This inventor holds 1 USPTO granted patent. Top assignee: Ambra Bioscience LLC. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Christopher R J Jones: Innovator in Chemosensory Receptor Ligand-Based Therapies
Introduction
Christopher R J Jones is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical therapies, particularly in the treatment of metabolic diseases. His innovative work focuses on the use of chemosensory receptor ligands to address conditions such as diabetes and obesity.
Latest Patents
Christopher R J Jones holds a patent for "Chemosensory receptor ligand-based therapies." This patent outlines compositions and methods for treating diabetes, obesity, and other metabolic diseases, disorders, or conditions using chemosensory receptor ligands. Additionally, it includes pharmaceutical compositions that are useful for the methods described in the patent.
Career Highlights
Jones is currently associated with Ambra Bioscience LLC, where he continues to develop and refine his innovative approaches to healthcare. His work is pivotal in advancing therapeutic options for patients suffering from metabolic disorders.
Collaborations
Some of his notable coworkers include Alain D Baron and Martin R Brown, who contribute to the collaborative efforts at Ambra Bioscience LLC.
Conclusion
Christopher R J Jones is a distinguished inventor whose work in chemosensory receptor ligand-based therapies is paving the way for new treatments in metabolic health. His contributions are vital to the ongoing advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile